Source: Health Products Regulatory Authority (ZA) Revision Year: 2022 Publisher: Ingelheim Pharmaceuticals (Pty) Ltd, 407 Pine Avenue, Randburg, South Africa
Pharmacological classification: A 10.2.1 Bronchodilators – Inhalants
Fenoterol hydrobromide is a beta 2 selective bronchodilator with a direct local effect which relaxes the constricted bronchial muscles.
The bronchodilator effect lasts 3–5 hours.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
